Innovator IBD 50 ETF (NYSEARCA:FFTY) Shares Up 3.7% – Still a Buy?

Innovator IBD 50 ETF (NYSEARCA:FFTY)’s share price shot up 3.7% during trading on Tuesday . The stock traded as high as $40.62 and last traded at $40.27. 85,070 shares traded hands during mid-day trading, an increase of 2% from the average session volume of 83,208 shares. The stock had previously closed at $38.83.

Innovator IBD 50 ETF Trading Up 3.7%

The stock has a market capitalization of $92.62 million, a PE ratio of 30.34 and a beta of 1.47. The company’s 50-day moving average is $36.63 and its 200 day moving average is $36.71.

Hedge Funds Weigh In On Innovator IBD 50 ETF

Several hedge funds and other institutional investors have recently modified their holdings of the stock. NewEdge Advisors LLC raised its position in shares of Innovator IBD 50 ETF by 48.4% in the 4th quarter. NewEdge Advisors LLC now owns 3,883 shares of the company’s stock valued at $135,000 after purchasing an additional 1,266 shares during the last quarter. Kestra Advisory Services LLC purchased a new position in Innovator IBD 50 ETF during the 4th quarter worth approximately $72,000. Jane Street Group LLC purchased a new position in Innovator IBD 50 ETF during the 4th quarter worth approximately $282,000. HRT Financial LP purchased a new position in Innovator IBD 50 ETF during the 4th quarter worth approximately $507,000. Finally, Janney Montgomery Scott LLC raised its position in Innovator IBD 50 ETF by 137.3% during the 4th quarter. Janney Montgomery Scott LLC now owns 15,310 shares of the company’s stock worth $533,000 after buying an additional 8,857 shares during the last quarter.

About Innovator IBD 50 ETF

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.